These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 38897820)
21. Increased incidence of lobular breast cancer in women treated with hormone replacement therapy: implications for diagnosis, surgical and medical treatment. Biglia N; Mariani L; Sgro L; Mininanni P; Moggio G; Sismondi P Endocr Relat Cancer; 2007 Sep; 14(3):549-67. PubMed ID: 17914088 [TBL] [Abstract][Full Text] [Related]
22. Breast biomarkers profile of invasive lobular carcinoma in a cohort of arab women shows no significant differences from carcinoma of no special type. Al Nemer A Afr Health Sci; 2022 Dec; 22(4):10-15. PubMed ID: 37092099 [TBL] [Abstract][Full Text] [Related]
23. Integration of Pathological Criteria and Immunohistochemical Evaluation for Invasive Lobular Carcinoma Diagnosis: Recommendations From the European Lobular Breast Cancer Consortium. De Schepper M; Koorman T; Richard F; Christgen M; Vincent-Salomon A; Schnitt SJ; van Diest PJ; Zels G; Mertens F; Maetens M; Vanden Bempt I; Harbeck N; Nitz U; Gräser M; Kümmel S; Gluz O; Weynand B; Floris G; Derksen PWB; Desmedt C; Mod Pathol; 2024 Jul; 37(7):100497. PubMed ID: 38641322 [TBL] [Abstract][Full Text] [Related]
24. Novel markers for differentiation of lobular and ductal invasive breast carcinomas by laser microdissection and microarray analysis. Turashvili G; Bouchal J; Baumforth K; Wei W; Dziechciarkova M; Ehrmann J; Klein J; Fridman E; Skarda J; Srovnal J; Hajduch M; Murray P; Kolar Z BMC Cancer; 2007 Mar; 7():55. PubMed ID: 17389037 [TBL] [Abstract][Full Text] [Related]
25. Molecular profiling pleomorphic lobular carcinomas of the breast: evidence for a common molecular genetic pathway with classic lobular carcinomas. Simpson PT; Reis-Filho JS; Lambros MB; Jones C; Steele D; Mackay A; Iravani M; Fenwick K; Dexter T; Jones A; Reid L; Da Silva L; Shin SJ; Hardisson D; Ashworth A; Schmitt FC; Palacios J; Lakhani SR J Pathol; 2008 Jul; 215(3):231-44. PubMed ID: 18473330 [TBL] [Abstract][Full Text] [Related]
26. Lobular-Like Features and Outcomes of Mixed Invasive Ductolobular Breast Cancer (MIDLC): Insights from 54,403 Stage I-III MIDLC Patients. Lohani KR; Hoskin TL; Day CN; Yasir S; Boughey JC; Degnim AC Ann Surg Oncol; 2024 Feb; 31(2):936-946. PubMed ID: 37872454 [TBL] [Abstract][Full Text] [Related]
28. Distinct clinical and prognostic features of infiltrating lobular carcinoma of the breast: combined results of 15 International Breast Cancer Study Group clinical trials. Pestalozzi BC; Zahrieh D; Mallon E; Gusterson BA; Price KN; Gelber RD; Holmberg SB; Lindtner J; Snyder R; Thürlimann B; Murray E; Viale G; Castiglione-Gertsch M; Coates AS; Goldhirsch A; J Clin Oncol; 2008 Jun; 26(18):3006-14. PubMed ID: 18458044 [TBL] [Abstract][Full Text] [Related]
29. Analysis of prognosis in different subtypes of invasive lobular carcinoma using the Japanese National Cancer Database-Breast Cancer Registry. Adachi Y; Asaga S; Kumamaru H; Kinugawa N; Sagara Y; Niikura N; Jinno H; Saji S; Toi M Breast Cancer Res Treat; 2023 Oct; 201(3):397-408. PubMed ID: 37479943 [TBL] [Abstract][Full Text] [Related]
30. Immune Infiltration in Invasive Lobular Breast Cancer. Desmedt C; Salgado R; Fornili M; Pruneri G; Van den Eynden G; Zoppoli G; Rothé F; Buisseret L; Garaud S; Willard-Gallo K; Brown D; Bareche Y; Rouas G; Galant C; Bertucci F; Loi S; Viale G; Di Leo A; Green AR; Ellis IO; Rakha EA; Larsimont D; Biganzoli E; Sotiriou C J Natl Cancer Inst; 2018 Jul; 110(7):768-776. PubMed ID: 29471435 [TBL] [Abstract][Full Text] [Related]
31. Tumor microenvironment in invasive lobular carcinoma: possible therapeutic targets. Nakagawa S; Miki Y; Miyashita M; Hata S; Takahashi Y; Rai Y; Sagara Y; Ohi Y; Hirakawa H; Tamaki K; Ishida T; Watanabe M; Suzuki T; Ohuchi N; Sasano H Breast Cancer Res Treat; 2016 Jan; 155(1):65-75. PubMed ID: 26715212 [TBL] [Abstract][Full Text] [Related]
32. The estrogen receptor coactivator AIB1 is a new putative prognostic biomarker in ER-positive/HER2-negative invasive lobular carcinoma of the breast. Narbe U; Sjöström M; Forsare C; Bendahl PO; Alkner S; Leeb-Lundberg LMF; Lövgren K; Rydén L; Ingvar C; Fernö M Breast Cancer Res Treat; 2019 Jun; 175(2):305-316. PubMed ID: 30796653 [TBL] [Abstract][Full Text] [Related]
33. Targetable ERBB2 mutation status is an independent marker of adverse prognosis in estrogen receptor positive, ERBB2 non-amplified primary lobular breast carcinoma: a retrospective in silico analysis of public datasets. Kurozumi S; Alsaleem M; Monteiro CJ; Bhardwaj K; Joosten SEP; Fujii T; Shirabe K; Green AR; Ellis IO; Rakha EA; Mongan NP; Heery DM; Zwart W; Oesterreich S; Johnston SJ Breast Cancer Res; 2020 Aug; 22(1):85. PubMed ID: 32782013 [TBL] [Abstract][Full Text] [Related]
34. Invasive lobular breast cancer: the prognostic impact of histopathological grade, E-cadherin and molecular subtypes. Engstrøm MJ; Opdahl S; Vatten LJ; Haugen OA; Bofin AM Histopathology; 2015 Feb; 66(3):409-19. PubMed ID: 25283075 [TBL] [Abstract][Full Text] [Related]
35. Patient treatment and outcome after breast cancer orbital and periorbital metastases: a comprehensive case series including analysis of lobular versus ductal tumor histology. Blohmer M; Zhu L; Atkinson JM; Beriwal S; Rodríguez-López JL; Rosenzweig M; Brufsky AM; Tseng G; Lucas PC; Lee AV; Oesterreich S; Jankowitz RC Breast Cancer Res; 2020 Jun; 22(1):70. PubMed ID: 32586354 [TBL] [Abstract][Full Text] [Related]
36. Chromatin accessibility landscape and active transcription factors in primary human invasive lobular and ductal breast carcinomas. Lee S; Osmanbeyoglu HU Breast Cancer Res; 2022 Jul; 24(1):54. PubMed ID: 35906698 [TBL] [Abstract][Full Text] [Related]
37. Single-Cell Transcriptomic Heterogeneity in Invasive Ductal and Lobular Breast Cancer Cells. Chen F; Ding K; Priedigkeit N; Elangovan A; Levine KM; Carleton N; Savariau L; Atkinson JM; Oesterreich S; Lee AV Cancer Res; 2021 Jan; 81(2):268-281. PubMed ID: 33148662 [TBL] [Abstract][Full Text] [Related]
38. Comparative Long-term Study of a Large Series of Patients with Invasive Ductal Carcinoma and Invasive Lobular Carcinoma. Loco-Regional Recurrence, Metastasis, and Survival. García-Fernández A; Lain JM; Chabrera C; García Font M; Fraile M; Barco I; Torras M; Reñe A; González S; González C; Piqueras M; Veloso E; Cirera L; Pessarrodona A; Giménez N Breast J; 2015; 21(5):533-7. PubMed ID: 26190560 [TBL] [Abstract][Full Text] [Related]
39. E-cadherin immunohistochemical expression in invasive lobular carcinoma of the breast: correlation with morphology and CDH1 somatic alterations. Grabenstetter A; Mohanty AS; Rana S; Zehir A; Brannon AR; D'Alfonso TM; DeLair DF; Tan LK; Ross DS Hum Pathol; 2020 Aug; 102():44-53. PubMed ID: 32599083 [TBL] [Abstract][Full Text] [Related]
40. Comprehensive Phenotypic Characterization of Human Invasive Lobular Carcinoma Cell Lines in 2D and 3D Cultures. Tasdemir N; Bossart EA; Li Z; Zhu L; Sikora MJ; Levine KM; Jacobsen BM; Tseng GC; Davidson NE; Oesterreich S Cancer Res; 2018 Nov; 78(21):6209-6222. PubMed ID: 30228172 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]